At the same time, STING inhibitors may lead to excessive suppression of the body’s immune system, thus impairing the immune surveillance of tumor cells to increase the risk of tumor occurrence [269], and weakening antiviral and antibacterial responses that could result in severe infections [189]. The gene discussed is STING1; the disease is neoplasm.